Literature DB >> 18414048

Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features.

Jenny Paupert1, Véronique Mansat-De Mas, Cécile Demur, Bernard Salles, Catherine Muller.   

Abstract

The metalloprotease 9 (MMP-9), a known mediator of tumour invasion, is secreted as a 92 kDa pro-form but a non-secreted variant of 85 Kda has been described. The importance of this variant pro-form in tumor progression remains poorly defined. We previously showed that the DNA repair protein Ku interacts at the cell surface of leukaemia cell lines with the 85 Kda pro-form of MMP-9 and these Ku/MMP-9 complexes regulates cell invasion, highlighting their importance in haematological malignancies. We demonstrate here that all samples of acute myeloid leukaemia (AML) blasts purified from bone marrow of 16 affected patients express the 85 Kda form of MMP-9. However, only AML that display monocytic lineage markers (AML4/5) express this form at the cell surface with co-expression of the membrane associated form of Ku. Blocking antibodies directed against Ku or MMP-9 specifically inhibited cell invasion of those expressing Ku/MMP-9 on the cell surface. The membrane form of Ku might represent an important factor in the exposition to the cell surface of this specific MMP-9 pro-form in AML with monocytic features. These results might have important functional significance in the occurrence of extra-medullar infiltrates of leukaemia cells that occurs frequently during the onset of monocyte-related AML sub-types.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18414048     DOI: 10.4161/cc.7.8.5645

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts.

Authors:  Q Li; Y Wu; S Fang; L Wang; H Qi; Y Zhang; J Zhang; W Li
Journal:  Cancer Gene Ther       Date:  2015-04-03       Impact factor: 5.987

2.  The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.

Authors:  Jérôme Devy; Farid Ouchani; Christelle Oudot; Jean Jacques Helesbeux; Enguerran Vanquelef; Stéphanie Salesse; Fanja Rabenoelina; Siana Al-Khara; Isabelle Letinois; Olivier Duval; Laurent Martiny; Emmanuelle Charpentier
Journal:  Invest New Drugs       Date:  2010-03-28       Impact factor: 3.850

3.  Molecular biological characteristics of the recruitment of hematopoietic stem cells from bone marrow niche in chronic myeloid leukemia.

Authors:  Biao Zhu; Jianbo Zhang; Jiao Chen; Chenglong Li; Xiaodong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia.

Authors:  Xishan Zhu; Ziying Lin; Jing Du; Xu Zhou; Lawei Yang; Gang Liu
Journal:  Mol Cell Biochem       Date:  2014-01-03       Impact factor: 3.396

5.  Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.

Authors:  Saran Feng; Jiannong Cen; Yihong Huang; Hongjie Shen; Li Yao; Yuanyuan Wang; Zixing Chen
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

6.  Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications.

Authors:  Amir Foroushani; Rupesh Agrahari; Roderick Docking; Linda Chang; Gerben Duns; Monika Hudoba; Aly Karsan; Habil Zare
Journal:  BMC Med Genomics       Date:  2017-03-16       Impact factor: 3.063

7.  Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness.

Authors:  Chiara Pirillo; Flora Birch; Floriane S Tissot; Sara Gonzalez Anton; Myriam Haltalli; Valentina Tini; Isabella Kong; Cécile Piot; Ben Partridge; Constandina Pospori; Karen Keeshan; Salvatore Santamaria; Edwin Hawkins; Brunangelo Falini; Andrea Marra; Delfim Duarte; Chiu Fan Lee; Edward Roberts; Cristina Lo Celso
Journal:  Blood Adv       Date:  2022-05-24

8.  Gan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model.

Authors:  Fon-Chang Liu; Chun-Hsu Pan; Ming-Tsung Lai; Shu-Jen Chang; Jing-Gung Chung; Chieh-Hsi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-17       Impact factor: 2.629

9.  Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression.

Authors:  Antonietta Rosella Farina; Andrew Reay Mackay
Journal:  Cancers (Basel)       Date:  2014-01-27       Impact factor: 6.639

10.  8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells.

Authors:  Pei-Shan Wu; Chih-Yang Wang; Pin-Shern Chen; Jui-Hsiang Hung; Jui-Hung Yen; Ming-Jiuan Wu
Journal:  Biomedicines       Date:  2021-12-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.